COMPREHENSIVE DIAGNOSTICS OF ACUTE MYELOID LEUKEMIA BY WHOLE TRANSCRIPTOME RNA SEQUENCING

EHA Library, Marieke Griffioen, 266062

DEEP RESPONSE AFTER CPX-351 TREATMENT IN T-AML AND MRC-AML: A REPORT FROM A MULTICENTRIC FRENCH COHORT

EHA Library, Edmond Chiche, 266063

TREATMENT INTENSIFICATION WITH FLAG-IDA MAY IMPROVE DISEASE CONTROL IN YOUNGER PATIENTS WITH SECONDARY AML WHICH MANIFESTS ITSELF WITH LONGER FOLLOW-UP: LONG-TERM ANALYSIS OF THE MRC AML15 TRIAL

EHA Library, Nigel Russell, 266064

GENE MUTATION PROFILE IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL)

EHA Library, Lingyan Zhang, 266065

COMBINING FLOW CYTOMETRY-BASED LEUKEMIC CELL ENRICHMENT AND MUTATIONAL ANALYSIS FOR DETECTION OF RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA: A PILOT STUDY

EHA Library, Albert Wölfler, 266066

RISK ASSESSMENT OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH ACUTE LEUKEMIA AND CONCOMITANT ISCHEMIC HEART DISEASE

EHA Library, Tetiana Lymanets, 266067

DECIPHERING THE ABERRANT IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA DEVELOPMENT AND ITS ROLE IN CHEMOTHERAPY RESPONSE

EHA Library, Heng Mei, 266068

FT-2102, AN IDH1M INHIBITOR, COMBINED WITH AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS): RESULTS FROM A PHASE 1 STUDY

EHA Library, Jorge E. Cortes, 266069

IS ACUTE MYELOBLASTIC LEUKEMIA IN CHILDREN UNDER TWO YEARS OF AGE A SPECIFIC ENTITY? A REPORT FROM THE FRENCH ELAM02 STUDY GROUP.

EHA Library, Sophie Blais, 266070

USING NEXT-GENERATION SEQUENCING TO PREDICT RESPONSE TO SALVAGE CHEMOTHERAPY WITH HIGH DOSE CYTARABINE AND MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Jonathan Canaani, 266071

GLASDEGIB WITH LDAC IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNSUITABLE FOR INTENSIVE CHEMOTHERAPY: EFFECTS ON TRANSFUSIONS AND MARROW RECOVERY VS LDAC ALONE

EHA Library, Eunice S Wang, 266072

VENETOCLAX IN COMBINATION WITH LOW DOSE CYTARABINE AND/OR ACTINOMYCIN D IN REAL LIFE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

EHA Library, Andrius Žučenka, 266073

UNMANIPULATED HID COMPARED TO MUD AND ISD HAD SIMILAR GRAFT ANTI-LEUKEMIA EFFECT ON MYELOABLATIVE HSCT FOR AML IN CR

EHA Library, Yue Lu, 266074

NAT10 UPREGULATION INDICATES A POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA

EHA Library, Rong Hu, 266075

QUALITY OF LIFE EVALUATION IN LONG TERM SURVIVORS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE

EHA Library, Francesco Tarantini, 266076

ALICE: AN AML STUDY WITH LSD1 INHIBITION IN COMBINATION WITH AZACITIDINE IN THE ELDERLY

EHA Library, Carlos Buesa, 266077

DECITABINE COMBINED WITH HAAG AS INDUCTION CHEMOTHERAPY FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Xiaowen Tang, 266078

BST-236 - A NOVEL SAFE AND EFFECTIVE FIRST-LINE THERAPY FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA UNFIT FOR STANDARD CHEMOTHERAPY. SUMMARY OF CLINICAL RESULTS TO DATE

EHA Library, Jessica K Altman, 266079

INTENSIVE TREATMENT OF ELDERLY AML PATIENTS IS SAFE AND FEASIBLE, PRINCESS MARGARET CANCER CENTRE EXPERIENCE.

EHA Library, Georgina Stefania Daher Reyes, 266080

CLI24-001: FIRST IN HUMAN STUDY OF SEL24/MEN1703, AN ORAL DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Simone Baldini, 266081

THE EFFECT OF MODERN THERAPEUTICS IN ADULT ACUTE MYELOID LEUKEMIA (AML): POPULATION-BASED ANALYSIS OF LONG-TERM OUTCOMES FROM THE MANITOBA CANCER REGISTRY

EHA Library, Laura Tapley, 266082

A RETROSPECTIVE STUDY OF MYELOID LEUKAEMIA IN CHILDREN WITH DOWN SYNDROME IN IRELAND

EHA Library, Gavin Dowling, 266083

OCCUPATIONAL PESTICIDES EXPOSURE IS ASSOCIATED WITH AN INCREASED RISK OF ACUTE MYELOID LEUKEMIA: A META-ANALYSIS OF CASE-CONTROL STUDIES INCLUDING 2981 PATIENTS AND 248705 CONTROLS

EHA Library, Amélie FOUCAULT, 266084

ZELLA-101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

EHA Library, Stephen ANTHONY, 266085

EARLY ADMISSION IN INTENSIVE CARE UNIT IS ASSOCIATED WITH LOWER MORBIDITY AND MORTALITY IN ACUTE MYELOID LEUKEMIA WITH HYPERLEUKOCYTOSIS: A RETROSPECTIVE ANALYSIS.

EHA Library, Mottaln Mottal, 266086

MIDOSTAURIN IN COMBINATION WITH INTENSIVE CHEMOTHERAPY IS SAFE AND ASSOCIATED WITH IMPROVED REMISSION AND HIGHER TRANSPLANT RATES IN REMISSION - A MULTI-CENTER HISTORICAL CONTROL STUDY

EHA Library, Tamar Berger, 266087

POPULATION PHARMACOKINETIC (POPPK) AND CONCENTRATION-QTC ANALYSIS OF QUIZARTINIB IN PATIENTS (PTS) WITH FLT3-ITD-POSITIVE RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Dongwoo Kang, 266088

SOCIOECONOMIC CONSEQUENCES AND OVERALL COSTS PER PATIENT WITH ACUTE MYELOID LEUKAEMIA (AML) IN SWEDEN - A POPULATION-BASED STUDY USING MULTIPLE NATIONAL REGISTRIES

EHA Library, Simona Vertuani, 266089

INCIDENCE AND PROGNOSTIC IMPACT OF A BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM-LIKE PHENOTYPE IN AML PATIENTS.

EHA Library, Fabio Guolo, 266090

A PHASE 1B/2 CLINICAL STUDY OF TARGETED IDH1 INHIBITION WITH IVOSIDENIB, IN COMBINATION WITH THE BCL-2 INHIBITOR VENETOCLAX, FOR PATIENTS WITH IDH1-MUTATED (MIDH1) MYELOID MALIGNANCIES.

EHA Library, Courtney DiNardo, 266091

LOW-DOSE CYTARABINE WITH OR WITHOUT GLASDEGIB IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA: LONG-TERM ANALYSIS OF A PHASE 2 RANDOMIZED TRIAL

EHA Library, Cristina papayannidis, 266092

PHASE 3 EXPLORATORY ANALYSIS OF OUTCOMES IN OLDER ADULTS WITH NEWLY DIAGNOSED, HIGH-RISK/SECONDARY AML WHO ACHIEVED REMISSION WITH CPX-351 VERSUS 7+3 INDUCTION

EHA Library, Stefan Faderl, 266093

IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R-CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY

EHA Library, Franck Morschhauser, 266094

POPULATION-BASED STUDY ON DIFFERENT REGIMENS OF R-CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA IN THE NETHERLANDS SUPPORTS THE USE OF 6 CYCLES OF R-CHOP21

EHA Library, Djamila Issa, 266095

UPDATE OF THE SINGLE-ARM PHASE II L-MIND STUDY OF MOR208 PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: HIGH OVERALL RESPONSE RATES IN PATIENT SUBGROUPS WITH POOR PROGNOSIS

EHA Library, Johannes Düll, 266096

COMPARISON OF RITUXIMAB DOSE-ADJUSTED EPOCH (R-DA-EPOCH) WITH RITUXIMAB-CHOP (R-CHOP) CHEMOTHERAPY IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL)

EHA Library, Theodoros Vassilakopoulos, 266097

LISOCABTAGENE MARALEUCEL TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN LYMPHOMA AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA: INITIAL RESULTS FROM TRANSCEND NHL 001

EHA Library, Jeremy Abramson, 266098

EARLY RESPONSE OBSERVATION OF PEDIATRIC PATIENTS WITH BURKITT'S LYMPHOMA TREATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

EHA Library, Wenqun zhang, 266099

DOSE ESCALATION OF TINOSTAMUSTINE IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LYMPHOID MALIGNANCIES

EHA Library, Delphine Remmy, 266100

REDUCED-INTENSITY IMMUNOCHEMOTHERAPY WITHOUT VINCRISTINE IN ELDERLY PATIENTS OLDER THAN 80 YEARS OLD WITH DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTRE, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL

EHA Library, Isao Yoshida, 266101

CENTRAL NERVOUS SYSTEM RELAPSE IN DIFFUSE LARGE B CELL LYMPHOMA: RISK FACTORS AND ROLE OF INTRATHECAL PROPHYLAXIS.

EHA Library, Eleonora ALMA, 266102

THE IMPACT OF EZH2 MUTATIONS (Y641N/Y641F/Y641H/Y641S) ON DISEASE-FREE SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A STROBE-COMPLIANT COHORT STUDY

EHA Library, Myrna Candelaria, 266103

OSTEOPOROSIS AND LOW-ENERGY FRACTURES AFTER TREATMENT FOR LYMPHOMA WITH CORTICOSTEROID-CONTAINING IMMUNOCHEMOTHERAPY: A DANISH NATIONWIDE COHORT STUDY

EHA Library, Joachim Baech, 266104

ANALYSES OF CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY BY AGE AND LYMPHODEPLETING CHEMOTHERAPY USE IN ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH TISAGENLECLEUCEL

EHA Library, Richard Maziarz, 266105

A PHASE 2 STUDY OF OFATUMUMAB IN COMBINATION WITH HYPER-CVAD/MA IN PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA

EHA Library, Pallawi Torka, 266106

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS OVER 33 YEARS: A SINGLE-CENTRE EXPERIENCE

EHA Library, MARTA LOPES, 266107

PROGNOSTIC FACTORS AND IMMUNOHISTOCHEMICAL PROFILE IN PRIMARY REFRACTORY AND RECURRENT DIFFUSE LARGE B-CELL LYMPHOMAS

EHA Library, Henrik Lampikoski, 266108

IMPACT OF LATE RELAPSES ON OUTCOMES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Priyanka Raheja Makhija, 266109

A SYSTEMATIC REVIEW OF THE CLINICAL EFFICACY OF TREATMENTS IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)

EHA Library, Per-Olof Thuresson, 266110

ISOLATED PRIMARY ADRENAL LYMPHOMA (IPAL) - AN EMERGING LYMPHOMA ENTITY? RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Majidi Majidi, 266111

RESPONSES TO R-CHOP CHEMOTHERAPY INCORPORATING BIOSIMILAR RITUXIMAB (TRUXIMA®) FOR THE FIRST LINE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA - INITIAL EXPERIENCE AT UNIVERSITY COLLEGE LONDON HOSPITAL

EHA Library, Simon Cheesman, 266112

NEW TREATMENT FOR DOUBLE/TRIPLE HIT LYMPHOMA WITH DOSE INTENSE PROTOCOL: RITUXIMAB,DOXORUBICIN,ETOPOSIDE,PREDNISOLONE/GEMCITABINE+OXALIPLATIN SHAWING BETTER SURVIVAL RATE

EHA Library, Maher Salamoon, 266113

REAL WORLD CLINICAL EFFECTIVENESS AND SAFETY OF CT-P10 IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: INTERIM RESULTS FROM A EUROPEAN NON-INTERVENTIONAL POST-AUTHORISATION SAFETY STUDY

EHA Library, Pier Luigi Zinzani, 266114

CLINICAL VALUE OF DIFFUSION-WEIGHTED WHOLE-BODY IMAGING WITH BACKGROUND BODY SIGNAL SUPPRESSION IN NEWLY DIAGNOSED LYMPHOMA PATIENTS

EHA Library, Haiwen Huang, 266115

THE CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH AGGRESSIVE LARGE CELL LYMPHOMA AND DIABETES MELLITUS

EHA Library, Oren Pasvolsky, 266116

ELEVATION OF SERUM IL-10 IS ASSOCIATED WITH ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA WHO WERE TREATED WITH R-CHOP

EHA Library, Jun Ho Yi, 266117

IMPORTANCE OF DIAGNOSIS-TO-TREATMENT INTERVAL IN NEWLY DIAGNOSED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Masahiro Yoshida, 266118

A DUAL CENTRE EXPERIENCE OF HAEMOPHAGOCYTOSIS REVEALS ULTRA-HIGH FERRITIN (>50,000 NG/ML) AND NEUTROPENIA AS PREDICTORS OF MORTALITY.

EHA Library, Catherine hockings, 266119

VENOUS THROMBOSIS AND BASELINE C-REACTIVE PROTEIN ARE INDEPENDENT PROGNOSTIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA AND IDENTIFY A GROUP OF PATIENTS WITH SIGNIFICANTLY INFERIOR OUTCOMES

EHA Library, Mark Grech, 266120

REAL-WORLD TREATMENT PATTERNS OF PATIENTS DIAGNOSED WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE UNITED STATES (US)

EHA Library, Xiaoqin Yang, 266121

APPROACH TO DOUBLE HIT LYMPHOMA (DHL) DIAGNOSIS AND TREATMENT IN EUROPE - A CROSS-SECTION STUDY OF EHA LYMPHOMA WORKING PARTY (EHA LYG)

EHA Library, Igor Aurer, 266122

DOUBLE-HIT DIFFUSE LARGE B-CELL LYMPHOMA IN TAIWAN IS PREDOMINANTLY BCL6-REARRANGED AND OVEREXPRESSION OF MYC AND BCL6 IS NOT A GOOD SURROGATE FOR SCREENING

EHA Library, T-Y Chao, 266123

RITUXIMAB DOSE ASSOCIATED WITH OVERALL SURVIVAL IN DIFFUSE LARGE B CELL LYMPHOMA

EHA Library, Jee Hyun Kong, 266124

REAL - LIFE DATA ON ROMIDEPSIN TREATMENT ‎FOR RELAPSED AND REFRACTORY PERIPHERAL AND ‎CUTANEOUS T-CELL LYMPHOMA - A ‎MULTICENTER NATIONAL OBSERVATIONAL STUDY

EHA Library, Shai Shimony, 266125

VITAMIN D INSUFFICIENCY AND PROGNOSIS IN LYMPHOMA

EHA Library, Blanca Sanchez-Gonzalez, 266126

RECOMBINANT FACTOR VIII FC FUSION PROTEIN IN SURGERIES IN HEMOPHILIA A

EHA Library, Vinod Patil, 266127

PREDICTORS OF TREATMENT RESPONSE TO IMMUNOSUPPRESSANTS IN ACQUIRED HEMOPHILIA A

EHA Library, Wai Nga Grace Lau, 266128

INTRACRANIAL HEMORRHAGE IN IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTRED STUDY OF 36 PATIENTS

EHA Library, Peng Zhao, 266129

MODE OF DELIVERY IN NEWBORNS WITH HEMOPHILIA: ASSOCIATION WITH FAMILY HISTORY/MATERNAL CARRIER STATUS, SEVERITY OF HEMOPHILIA AND INCIDENCE OF INTRACRANIAL/EXTRACRANIAL HEMORRHAGE

EHA Library, Aikaterini Michalopoulou, 266130

COST-EFFECTIVENESS OF EMICIZUMAB VERSUS BY-PASSING AGENTS IN PATIENTS WITH HAEMOPHILIA A AND FVIII INHIBITORS IN FRANCE

EHA Library, Benoit Polack, 266131

THE EFFECT OF ANTITHROMBOTIC STEWARDSHIP ON THE EFFICACY AND SAFETY OF ANTITHROMBOTIC THERAPY DURING AND AFTER HOSPITALIZATION IN TWO DUTCH HOSPITALS

EHA Library, Albert Dreijer, 266132

RISK OF BLEEDING COMPLICATIONS AND ATRIAL FIBRILLATION ASSOCIATED WITH IBRUTINIB TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Luca Pellegrini, 266133

EPIDURAL/SPINAL ANESTHESIA IN PREGNANT JEWISH ASHKENAZI WOMEN HETEROZYGOTES FOR FACTOR XI DEFICIENCY, A SINGLE CENTER PROSPECTIVE STUDY

EHA Library, Adi Abulafia, 266134

MUTATION SPECTRUM OF F8 GENE IN HEMOPHILIA A PATIENTS FROM RUSSIA

EHA Library, Olesya Pshenichnikova, 266135

EVALUATION OF THROMBOPOIETIN-RECEPTOR AGONISTS (TPO-RAS) «STOP-THERAPY» IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)

EHA Library, Maria Pankrashkina, 266136

ALRN-6924, A DUAL INHIBITOR OF MDMX AND MDM2 THAT CAUSES MINIMAL THROMBOCYTOPENIA IN PATIENTS, DISRUPTS DIFFERENT STAGES OF THROMBOPOIESIS COMPARED TO MDM2-ONLY INHIBITION

EHA Library, Allen Annis, 266137

DEVELOPMENT AND OPTIMISATION OF A FULLY HUMAN FVIII MIMETIC BISPECIFIC ANTIBODY FOR PATIENTS WITH HAEMOPHILIA A

EHA Library, Wei Wang, 266138

BIOLOGICAL AND CLINICAL FACTORS THAT FAVOR THE USE OF A SPECIFIC TPO-RA IN ITP PATIENTS. RESULTS FROM A SPANISH MULTICENTER STUDY

EHA Library, María Lozano, 266139

PATIENTS WITH HIGHER BODY MASS INDEX TREATED WITH DIRECT / NON VITAMIN K DEPENDENT ANTICOAGULANTS (DOAC / NOAC) EXPERIENCE WORSE CLINICAL OUTCOMES

EHA Library, Marko Lucijanic, 266140

LUSUTROMBOPAG FOR TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC LIVER DISEASE WHO ARE UNDERGOING PLANNED INVASIVE PROCEDURES: POOLED SAFETY ANALYSIS OF BLEEDING-RELATED ADVERSE EVENTS

EHA Library, Edoardo G. Giannini, 266141

COMPENSATORY MUTATIONS IN PROMOTERS OF TELOMERASE GENES ARE RARE IN TELOMERE BIOLOGY DISORDERS WITH BONE MARROW FAILURE.

EHA Library, Rebecca Voss, 266142

CRISPR/CAS9 MEDIATED ELANE KNOCKOUT ENABLES NEUTROPHILIC MATURATION OF HSPCS AND IPSCS OF SEVERE CONGENITAL NEUTROPENIA PATIENTS

EHA Library, Julia Skokowa, 266143

HIGH FREQUENCY ASXL1 MUTATIONS AND MULTIPLE SUBCLONAL PIGA MUTATIONS ARE OBSERVED IN CELLULAR AND CELL-FREE DNA IN PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

EHA Library, Georgie Ryland, 266144

THE INVOLVEMENT OF OXIDATIVE STRESS, INFLAMMATION, AND DNA DAMAGE RESPONSE IN PATHOPHYSIOLOGY OF DIAMOND-BLACKFAN ANEMIA

EHA Library, Katarina Kapralova, 266145

ZEBRAFISH AS A NOVEL MODEL TO STUDY GATA2 HAPLOINSUFFICIENCY SYNDROMES

EHA Library, Emanuele gioacchino, 266146

PHARMACOKINETIC AND PHARMACODYNAMIC SIMILARITY OF ABP 959 WITH ECULIZUMAB: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE, PARALLEL-GROUP STUDY IN HEALTHY SUBJECTS

EHA Library, Vincent Chow, 266147

LONG TERM FOLLOW-UP OF PNH PATIENTS TREATED WITH THE SMART ANTI-HC5 ANTIBODY (SKY59/RO7112689) IN THE OPEN LABEL EXTENSION (OLE) OF THE COMPOSER TRIAL

EHA Library, Alexander Röth, 266148

57 PATIENTS WITH HAX1 ASSOCIATED CONGENITAL NEUTROPENIA: AN ANALYSIS OF THE EUROPEAN SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY (SCNIR)

EHA Library, Cornelia Zeidler, 266149

CONSTRUCTION OF A PROGNOSTIC MODEL FOR HLH IN ADULTS - ANALYSIS FROM THE PALG HLH IN ADULTS DATABASE

EHA Library, Rafal Machowicz, 266150

ALPS DISEASE AND ALPS PHENOTYPE: DISTINCT ENTITIES ?

EHA Library, Francesca Fioredda, 266151

TUNISIAN FANCONI ANEMIA REGISTRY (TFAR) REPORT, THE 2018 UPDATE

EHA Library, sondes Hadiji Mseddi, 266152

PATIENTS WITH SEVERE CHRONIC NEUTROPENIA SUBTYPES TREATED WITH BIOSIMILAR FILGRASTIM: A STUDY BY THE EUROPEAN BRANCH OF THE SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY

EHA Library, Cornelia Zeidler, 266153

HOW TELOMERE LENGTH SCREENING CAN BE HELPFUL FOR THE DIAGNOSIS OF CYTOPENIC PATIENTS?

EHA Library, Filomena Pierri, 266154

INTEGRATION OF GENOMIC AND EPIGENOMIC DATA REFINES THE REGULATORY MECHANISMS AND BIOLOGICAL SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA RISK LOCI

EHA Library, Renée Beekman, 266155

CHRONIC LYMPHOCYTIC LEUKEMIA INDUCES SKEWING OF (ANTIGEN-SPECIFIC) T CELL RESPONSES TOWARDS A DYSFUNCTIONAL SHORT-LIVED EFFECTOR PHENOTYPE

EHA Library, Anne Martens, 266156

A NOVEL REFINED PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMBINING IGH TRANSLOCATIONS AND NEXT-GENERATION SEQUENCING

EHA Library, Claudia Perez-Carretero, 266157

FUNCTIONAL HIERARCHY AMONG PRO-SURVIVAL BCL-2 MEMBERS IN DETERMINING RESISTANCE TO VENETOCLAX IN CLL

EHA Library, Marco Haselager, 266158

TP53 CLONAL AND SUBCLONAL ARCHITECTURE IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER IBRUTINIB TREATMENT

EHA Library, Luciana Cafforio, 266159

IN-VITRO DRUG SENSITIVITY SCREENING IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENT SAMPLES IDENTIFIES DRUG CANDIDATES FOR PRECISION CANCER THERAPY

EHA Library, Sigrid S. Skånland, 266160

ATR-CHK1 SIGNALING IS ACTIVE AND TARGETABLE IN QUIESCENT CLL CELLS

EHA Library, Miroslav Boudny, 266161